Ryan H Moy

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 10

Top Topics

Neoadjuvant Chemotherapy

Top Venues

Cancer research communications

JCO precision oncology

Targeted oncology

Cancer chemotherapy and pharmacology

This page only lists publications with an associated author ORCID identifier.

Publications

Naryan Rustgi, Sharon Wu, Timothy Samec, Phillip Walker, Joanne Xiu, Emil Lou, Sanjay Goel, Anwaar Saeed, Ryan H Moy
Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer. Cancer research communications (2024)
Naryan Rustgi, Sharon Wu, Timothy Samec, Phillip Walker, Joanne Xiu, Emil Lou, Sanjay Goel, Anwaar Saeed, Ryan H Moy
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer. Cancer research communications 4 (6) (2024)
Lawrence W Wu, Sung Joo Jang, Cameron Shapiro, Ladan Fazlollahi, Timothy C Wang, Sandra W Ryeom, Ryan H Moy
Diffuse Gastric Cancer: A Comprehensive Review of Molecular Features and Emerging Therapeutics. Targeted oncology (2024)
Naryan Rustgi, Sharon Wu, Timothy Samec, Phillip Walker, Joanne Xiu, Emil Lou, Sanjay Goel, Anwaar Saeed, Ryan H Moy
Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer. Cancer research communications (2024)
Naryan Rustgi, Sharon Wu, Timothy Samec, Phillip Walker, Joanne Xiu, Emil Lou, Sanjay Goel, Anwaar Saeed, Ryan H Moy
Molecular Landscape and Clinical Implication of CCNE1-amplified Esophagogastric Cancer. Cancer research communications 4 (6) (2024)
Brian S Henick, Ryan H Moy
TAPping Into PD-L1 Testing Efficiency for Gastroesophageal Cancer. JCO precision oncology 8 (2024)
Brian S Henick, Ryan H Moy
TAPping Into PD-L1 Testing Efficiency for Gastroesophageal Cancer. JCO precision oncology 8 (2024)
Naryan Rustgi, Sharon Wu, Timothy Samec, Phillip Walker, Joanne Xiu, Emil Lou, Sanjay Goel, Anwaar Saeed, Ryan H Moy
Molecular landscape and clinical implication of CCNE1-amplified esophagogastric cancer. Cancer research communications (2024)
Ryan H Moy, Megan Greally, Joanne F Chou, Jia Li, Avni M Desai, Sree B Chalasani, Elizabeth Won, David P Kelsen, David H Ilson, Yelena Y Janjigian, Marinela Capanu, Geoffrey Y Ku
Phase I/Ib study of crenolanib with ramucirumab and paclitaxel as second-line therapy for advanced esophagogastric adenocarcinoma. Cancer chemotherapy and pharmacology 89 (2) (2022)
Ryan H Moy, Henry S Walch, Marissa S Mattar, Walid K Chatila, Daniela Molena, Vivian E Strong, Laura H Tang, Steven B Maron, Daniel G Coit, David R Jones, Jaclyn F Hechtman, David B Solit, Nikolaus Schultz, Elisa de Stanchina, Yelena Y Janjigian
Defining and Targeting Esophagogastric Cancer Genomic Subsets With Patient-Derived Xenografts. JCO precision oncology 6 (2022)